Idelalisib (Zydelig) has been accepted for restricted use by NHS Scotland. you can read more & access the full guidance PDF from the download on the SMC website.
CLLSA have participated in the consultation process, it is rewarding to see this now gain approval.
SMC intitial guidance details:
following a full submission